NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers

(NIH/National Cancer Institute) Investigators at the National Cancer Institute and the Children's Oncology Group announce the opening of enrollment for NCI-COG Pediatric MATCH, a unique precision medicine clinical trial to explore whether targeted therapies can be effective for children and adolescents with solid tumors that harbor specific genetic mutations and have progressed during or after standard therapy.